Lecanemab received traditional approval in the U.S. in July 2023 for the treatment of early Alzheimer's disease (AD). This retrospective study was conducted to investigate the actual state of ...

Eisai (ESALF) and Eli Lilly (LLY) post new long-term data for thier Alzheimer's drugs Leqembi and Kisunla, respectively. Read more here.

"Cognition Therapeutics’ drug shows 129% cognitive decline arrest in mild Alzheimer’s" was originally created and published ...

Living through the pandemic aged our brains faster — even among people who never became sick with COVID-19, according to a ...

SaveHealth reports migraines are complex neurological conditions affecting over a billion globally, requiring comprehensive ...

TORONTO -- The antiviral agent valacyclovir demonstrated no benefit in early Alzheimer's disease, the phase II VALAD trial ...

The Alzheimer's Association U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER) ...

A structured approach to exercise, diet, brain training, social engagement and clinical testing yielded greater cognitive ...

The design of discrete phase-coded orthogonal waveforms is a critical issue in cognitive multiple-input multiple-output (MIMO) radar and communication systems. Typically, existing methods usually only ...

After the Grenfell fire there are many lessons to be learned. Architects and manufacturers should be able to demonstrate they acted to a reasonable standard of care and did everything practicable ...

One likelihood of Amtrak expansion in Ohio: Trains that travel through Cleveland during daylight hours. This photo was taken in 2007, during a trial period when the Lake Shore Limited, which ...

In people with overweight or obesity, once-weekly subcutaneous amycretin up to 60 mg had a safety and tolerability profile consistent with GLP-1 and amylin agonists. Although a high frequency of ...